These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 11847008

  • 21. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 22. Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome.
    Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, Keating M, Estey E, Albitar M.
    Br J Haematol; 2001 Aug; 114(2):290-5. PubMed ID: 11529846
    [Abstract] [Full Text] [Related]

  • 23. Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.
    Musolino C, Alonci A, Bellomo G, Loteta B, Quartarone E, Gangemi D, Massara E, Calabrò L.
    Eur J Haematol; 2004 Jun; 72(6):416-9. PubMed ID: 15128420
    [Abstract] [Full Text] [Related]

  • 24. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U, Günel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S, Ozkan S.
    Neoplasma; 2003 Jun; 50(1):41-6. PubMed ID: 12687277
    [Abstract] [Full Text] [Related]

  • 25. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 26. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT, Richter L, Sirjani D, Roxas C, Glinsmann-Gibson B, Frutiger Y, Grogan TM, List AF.
    Blood; 2001 Mar 01; 97(5):1427-34. PubMed ID: 11222390
    [Abstract] [Full Text] [Related]

  • 27. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J, Jankewicz J, Stepień H.
    Cytobios; 2000 Mar 01; 101(398):151-9. PubMed ID: 10755214
    [Abstract] [Full Text] [Related]

  • 28. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.
    Br J Haematol; 2007 May 01; 137(3):206-15. PubMed ID: 17408459
    [Abstract] [Full Text] [Related]

  • 29. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug 01; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 30. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 01; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 31. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P, Orpana A, Joensuu H.
    Clin Cancer Res; 1999 Mar 01; 5(3):487-91. PubMed ID: 10100697
    [Abstract] [Full Text] [Related]

  • 32. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
    Waltham M, Burnand KG, Collins M, Smith A.
    J Vasc Surg; 2000 Nov 01; 32(5):988-96. PubMed ID: 11054231
    [Abstract] [Full Text] [Related]

  • 33. A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
    Cortes J, Kantarjian H, Albitar M, Thomas D, Faderl S, Koller C, Garcia-Manero G, Giles F, Andreeff M, O'Brien S, Keating M, Estey E.
    Cancer; 2003 Mar 01; 97(5):1234-41. PubMed ID: 12599230
    [Abstract] [Full Text] [Related]

  • 34. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM, Fleisher M, Francis GL, Robbins RJ.
    J Clin Endocrinol Metab; 2002 Apr 01; 87(4):1737-42. PubMed ID: 11932308
    [Abstract] [Full Text] [Related]

  • 35. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK.
    Clin Cancer Res; 2002 Oct 01; 8(10):3193-7. PubMed ID: 12374688
    [Abstract] [Full Text] [Related]

  • 36. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
    Alexandrakis MG, Passam FH, Pappa CA, Sfiridaki K, Tsirakis G, Damilakis J, Stathopoulos EN, Kyriakou DS.
    Leuk Res; 2005 Jan 01; 29(1):41-6. PubMed ID: 15541473
    [Abstract] [Full Text] [Related]

  • 37. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J, Hu J, Cai J, Yang X, Yang Z.
    Chin Med J (Engl); 2003 May 01; 116(5):772-6. PubMed ID: 12875699
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
    Heeschen C, Dimmeler S, Hamm CW, Boersma E, Zeiher AM, Simoons ML, CAPTURE (c7E3 Anti-Platelet Therapy in Unstable REfractory angina) Investigators.
    Circulation; 2003 Feb 04; 107(4):524-30. PubMed ID: 12566361
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
    Bairey O, Zimra Y, Shaklai M, Rabizadeh E.
    Br J Haematol; 2001 May 04; 113(2):400-6. PubMed ID: 11380405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.